참고문헌 (37)

1. [1] Poewe W Seppi K Tanner CM Parkinson disease . Nat Rev Dis Primers 2017 ; 3 : 17013 . 28332488 

2. [2] Shi J Tian J Li T Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients: Protocol for a randomized, double-blind, placebo-controlled trial . Medicine (Baltimore) 2017 ; 96 : e8824 . 29390272 

3. [3] Hatano T Hattori N Kawanabe T An exploratory study of the efficacy and safety of Yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease . J Neural Transm (Vienna) 2014 ; 121 : 275 – 81 . 24169925 

4. [4] Hogl B Arnulf I Comella C Scales to assess sleep impairment in Parkinson's disease: critique and recommendations . Mov Disord 2010 ; 25 : 2704 – 16 . 20931631 

5. [5] Kurtis MM Rodriguez-Blazquez C Martinez-Martin P Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease . Parkinsonism Relat Disord 2013 ; 19 : 1152 – 5 . 23953775 

6. [6] Chung S Bohnen NI Albin RL Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities . J Clin Sleep Med 2013 ; 9 : 1131 – 7 . 24235893 

   상세보기

7. [7] Breen DP Vuono R Nawarathna U Sleep and circadian rhythm regulation in early Parkinson disease . JAMA Neurol 2014 ; 71 : 589 – 95 . 24687146 

   상세보기

8. [8] Bolitho SJ Naismith SL Rajaratnam SM Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease . Sleep Med 2014 ; 15 : 342 – 7 . 24529544 

9. [9] Rios Romenets S Creti L Fichten C Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease – a randomized study . Parkinsonism Relat Disord 2013 ; 19 : 670 – 5 . 23561946 

10. [10] Merlino G Lettieri C Mondani M Microsubthalamotomy improves sleep in patients affected by advanced Parkinson's disease . Sleep Med 2014 ; 15 : 637 – 41 . 24784787 

11. [11] Mizoguchi K Ikarashi Y Multiple psychopharmacological effects of the traditional Japanese kampo medicine Yokukansan, and the brain regions it affects . Front Pharmacol 2017 ; 8 : 149 . 28377723 

    상세보기

12. [12] Hayashi Y Ishida Y Okahara K An open-label trial of Yokukansan on sleep disturbance in Alzheimer's disease and other dementia . J Prev Alzheimers Dis 2015 ; 2 : 172 – 7 . 29226943 

13. [13] Egashira N Nogami A Iwasaki K Yokukansan enhances pentobarbital-induced sleep in socially isolated mice: possible involvement of GABA(A)—benzodiazepine receptor complex . J Pharmacol Sci 2011 ; 116 : 316 – 20 . 

14. [14] Ogawa Y Fujii Y Sugiyama R The role of the seven crude drug components in the sleep-promoting effect of Yokukansan . J Ethnopharmacol 2016 ; 177 : 19 – 27 . 26611914 

    상세보기

15. [15] Kawanabe T Yoritaka A Shimura H Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia . Prog Neuropsychopharmacol Biol Psychiatry 2010 ; 34 : 284 – 7 . 19948198 

16. [16] Ueki T Mizoguchi K Yamaguchi T Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice . J Ethnopharmacol 2015 ; 166 : 23 – 30 . 25732836 

    상세보기

17. [17] Shoji H Mizoguchi K Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of Yokukansan in rats . J Ethnopharmacol 2013 ; 149 : 93 – 102 . 23770052 

    상세보기

18. [18] Mizoguchi K Tanaka Y Tabira T Anxiolytic effect of a herbal medicine, Yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex . J Ethnopharmacol 2010 ; 127 : 70 – 6 . 19799980 

    상세보기

19. [19] Tamano H Yusuke E Ide K Influences of Yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats . Exp Anim 2016 ; 65 : 353 – 61 . 27245118 

    상세보기

20. [20] Aizawa R Kanbayashi T Saito Y Effects of Yoku-kan-san-ka-chimpi-hange on the sleep of normal healthy adult subjects . Psychiatry Clin Neurosci 2002 ; 56 : 303 – 4 . 12047606 

21. [21] Martinez-Martin P Visser M Rodriguez-Blazquez C SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease . Mov Disord 2008 ; 23 : 1681 – 8 . 18709672 

22. [22] Chaudhuri KR Pal S DiMarco A The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease . J Neurol Neurosurg Psychiatry 2002 ; 73 : 629 – 35 . 12438461 

    상세보기

23. [23] Arnaldi D Cordano C De Carli F Parkinson's Disease Sleep Scale 2: application in an Italian population . Neurol Sci 2016 ; 37 : 283 – 8 . 26520846 

    상세보기

24. [24] Tractenberg RE Singer CM Kaye JA Symptoms of sleep disturbance in persons with Alzheimer's disease and normal elderly . J Sleep Res 2005 ; 14 : 177 – 85 . 15910515 

25. [25] Kim HJ Reliability and validity of the 4-item version of the Korean Perceived Stress Scale . Res Nurs Health 2016 ; 39 : 472 – 9 . 27546692 

    상세보기

26. [26] Beattie Z Oyang Y Statan A Estimation of sleep stages in a healthy adult population from optical plethysmography and accelerometer signals . Physiol Meas 2017 ; 38 : 1968 – 79 . 29087960 

27. [27] Iber C Ancoli-Israel S Chesson A American Academy of Sleep Medicine . The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL : American Academy of Sleep Medicine ; 2007 . 

28. [28] Brichta L Greengard P Flajolet M Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems . Trends Neurosci 2013 ; 36 : 543 – 54 . 23876424 

    상세보기

29. [29] Altena E Van Der Werf YD Sanz-Arigita EJ Prefrontal hypoactivation and recovery in insomnia . Sleep 2008 ; 31 : 1271 – 6 . 18788652 

30. [30] Sun JJ Liu XM Shen CY Reduced prefrontal activation during verbal fluency task in chronic insomnia disorder: a multichannel near-infrared spectroscopy study . Neuropsychiatr Dis Treat 2017 ; 13 : 1723 – 31 . 28721053 

    상세보기

31. [31] Scarapicchia V Brown C Mayo C Functional magnetic resonance imaging and functional near-infrared spectroscopy: insights from combined recording studies . Front Hum Neurosci 2017 ; 11 : 419 . 28867998 

    상세보기

32. [32] Maidan I Nieuwhof F Bernad-Elazari H The role of the frontal lobe in complex walking among patients with Parkinson's disease and healthy older adults: An fNIRS Study . Neurorehabil Neural Repair 2016 ; 30 : 963 – 71 . 27221042 

33. [33] Patel S Ojo O Genc G A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson disease (ACCORD-PD) . J Clin Mov Disord 2017 ; 4 : 16 . 28852567 

34. [34] Trenkwalder C Kies B Rudzinska M Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER) . Mov Disord 2011 ; 26 : 90 – 9 . 21322021 

35. [35] Suzuki K Miyamoto T Miyamoto M Evaluation of cutoff scores for the Parkinson's disease sleep scale-2 . Acta Neurol Scand 2015 ; 131 : 426 – 30 . 25402773 

    상세보기

36. [36] Videnovic A Noble C Reid KJ Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease . JAMA Neurol 2014 ; 71 : 463 – 9 . 24566763 

    상세보기

37. [37] Garcia-Alberca JM Lara JP Cruz B Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment . J Nerv Ment Dis 2013 ; 201 : 251 – 7 . 23407210 

    상세보기